Cyclosporine (oral, modified)

سیکلوسپورین خوراکی (Neoral)

⚠ Unverified

🎗️ Antineoplastic And Immunomodulating AgentsCalcineurin inhibitor

Market / country: 🇺🇸 USA

Neoral (US)

🧮 Dose calculator

Rheumatoid arthritis · Regimen source: FDA Neoral · Dosage and Administration

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Hypersensitivity to cyclosporine. RA and psoriasis: abnormal renal function, uncontrolled hypertension or malignancy. Psoriasis: not with PUVA or UVB, methotrexate or other immunosuppressants, coal tar or radiation. FDA Neoral · Contraindications

Warnings

  • • Boxed warning: only by physicians experienced in immunosuppression; infection and lymphoma; nephrotoxicity and hypertension; psoriasis after PUVA — skin cancer risk. FDA Neoral · Boxed Warning

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Neoral · Pregnancy

    “Risk Summary Available data from published literature, including the Transplant Pregnancy Registry International, observational cohort studies, case-controlled studies, meta-analysis, case series, and case reports, over decades of use with cyclosporine in pregnancy have not identified a drug associated risk of major …”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Neoral · Nursing Mothers

    “Risk Summary Cyclosporine and its metabolites are present in human milk following oral and intravenous administration.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Neoral · Pediatric Use

    “The safety and efficacy of Neoral treatment in children with juvenile rheumatoid arthritis or psoriasis below the age of 18 have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Neoral · Geriatric Use

    “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav